CELF2 belongs to the family of RNA binding proteins implicated in mRNA splicing, editing, stability and translation. This gene is encoded in a single large gene spanning over 159 kilo bases located on chromosome 10 p13-p14 (between D10S547 and D10S223). This gene has 14 transcripts (splice variants) and the 3 major splice variants have distinct exon 1. This is an evolutionarily conserved ubiquitously expressed protein. The members of the CELF protein family contain two N-terminal RNA recognition motif (RRM) domains and one Cterminal RRM domain, and a divergent segment of 160-230 amino acids between second and third RRM domains. This divergent domain is unique to CELF2 proteins and has been shown to contain one or more activation molecules required for splicing activity. CELF2 has been shown to bind to the CUG and Au-rich element (ARE) in the target mRNA and shown to be implicated in muscular dystrophy and cancer.
DNA/RNA

Description
The human CELF2 gene contains 14 exons spanning over approximately 159 kb of the genomic DNA.
Transcription
Alternative promoters usage of CELF2 gene results in three transcript variants, where the variants 2 and 3 proteins have distinct exon 1 resulting in different 5' untranslated region (UTR) and have extended Nterminal sequences (Ramalingam et al., 2008) . There are totally 14 transcripts (splice variants) reported so far.
Protein
Description
This is an evolutionarily conserved protein. The members of the CELF protein family contain two N-terminal RNA recognition motif (RRM) domains and one C-terminal RRM domain, and a divergent segment of 160-230 amino acids between second and third RRM domains. This divergent domain is unique to CELF2 proteins and has been shown to contain one or more activation molecules required for splicing activity (figure 1). 
Expression
CELF2 is a ubiquitously expressed protein.
According to the NCBI Entrez GEO profiles the CELF2 is expressed in brain, heart, thymus, spleen, bone, tongue, stomach, intestine, pancreas, liver, breast, lung, kidney, testis, ovary, prostate, placenta and skin. In addition, according to expression atlas brain, bone marrow, heart, spleen, lymph node, ovary and adipose tissue has more expression of CELF2.
Localisation
CELF2 variant 1 is predominantly nuclear, while variants 2 and 3 are predominantly cytoplasmic (Ramalingam et al., 2008) . CELF2 variant 1 accumulates in the cytoplasm following radiation exposure (Mukhopadhyay et al., 2003a) . The C terminus of CELF2 transcript variant 1 is rich in arginine and lysine residues 13 amino acids (KRLKVQLKRSKND) 467 -480, which is common for NLS elements recognized by importin proteins. Ladd and Cooper, has reported that the Cterminus of CELF2 contains a strong nuclear localization signal overlapping the third RRM (Ladd and Cooper, 2004) . However, our unpublished data suggests that nuclear localization signal extends to the RNA recognition motif 1 and 2 domains. Finally, CELF2 has several leucine-rich motifs that resembles nuclear export signals recognized by the export protein CRM1.
Function
CELF2 is an RNA-binding protein implicated in the regulation of several post-transcriptional events. It has been shown to regulate pre-mRNA splicing (Faustino and Cooper, 2005) , mRNA editing (Anant et al., 2001) , mRNA translation and stability. CELF2 has been shown to be involved in alternative splicing of muscle specific genes including exon 5 of cardiac troponin T (Ladd et al., 2001) , exon 11 of insulin receptor, intron 2 of chloride channel 1, exons 5 and 21 of NMDAR-1, and the muscle-specific exon of α-actinin (Gromak et al., 2003) . Another function for CELF2 relates to its ability to bind to AU-rich sequences in 3' untranslated region (3' UTR) of the target mRNAs. Upon binding to the AU-rich sequences in cyclooxygenase-2 (COX-2) 3' UTR, CELF2 enhances the stability of COX-2 mRNA. However, CUGBP2 binding also results in the inhibition of its translation (Murmu et al., 2004) . In our earlier studies we have demonstrated that CELF2 can interact with HuR, a key inducer of RNA stability and translation, and competitively inhibit HuR function (Sureban et al., 2007) . Recently, platelet derived growth factor was shown to enhance CELF2 binding to COX-2 mRNA through increased phosphorylation of a tyrosine residue at position 39 in the protein (Xu et al., 2007) . These data suggest that posttranscriptional control mechanisms are in place to modulate the CELF2 function as a regulator of stability and translation of AU-rich transcripts.
Homology
According to GeneCards, the CELF2 has orthologs in 72 species including much lower organisms such as Danio rerio, Drosophila melanogaster, Caenorhabditis elegans, Xenopus tropicalis and Oryza sativa. Furthermore, in humans it has 6 paralogs from CELF1 to CELF6.
Mutations
Note According to GeneCards, there is 7518 single nucleotide polymorphism. However, Ensembl reports that CELF2 has 7768 SNPs. In addition, the Database of Genomic Variants shows that CELF2 has 18 structural variations.
Implicated in
Colon cancer
Note Putative tumor suppressor CELF2 expression is consistently reduced during neoplastic transformation suggesting that it might play a crucial role in tumor initiation and progression of colon cancer. In addition, CELF2 has been shown Haematol. 2015; 19(2) to induce mitotic catastrophic cell death in colon cancer (Ramalingam et al., 2012) .
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Pancreatic cancer
Note
Curcumin inhibits the pancreatic cancer growth by inducing the expression of CELF2 thereby regulating the levels of cyclooxygenase 2 and vascular endothelial growth factor expression (Subramaniam et al., 2011) .
Breast cancer
Note Breast cancer cells underwent apoptotic cell death in response to radiation injury and this was reversed by knockdown of CELF2 using specific siRNA (Mukhopadhyay et al., 2003b) .
Neuroblastoma
Note
Colchicine treatment of neuroblastoma cells resulted in apoptotic cell death and CELF2 has been shown to be involved in the process of cell death (Li et al., 2001 ).
Alzheimer's disease
Note It has been shown that variants in CUGBP2 on chromosome 10p, are associated with AD in those highest-risk APOE e4 homozygotes. This interaction observation is replicated in independent samples. CELF2 has one isoform that is expressed predominantly in neurons, and identification of such a new risk locus is important because of the severity of AD (Wijsman et al., 2011) .
Heart disease
Note
Arrhythmogenic right ventricular dysplasia is the most common cause of sudden cardiac death in the young in Italy and the second most common cause in the United States. One of the genes that was mapped to this is in the vicinity of chromosome 10p12-p14 and it is CELF2 (Li et al., 2001 ).
Ischemia
Note
The transient global ischemia induces the translational inhibition of genes with increased expression in normothermic mice. The author's correlate the translational inhibition with CELF2 expression and this might play an important role in the progress of neuronal injury after transient global ischemia (Otsuka et al., 2009 ).
Atrophy
Note
The differential expression of CELF2 has been confirmed with real-time RT-PCR in spinal cord and muscle of three different models of spinal muscular atrophy (Anderson et al., 2004) . Spinal and bulbar muscular atrophy (SBMA) is an inherited neurodegenerative disorder caused by the expansion of the polyglutamine (polyQ) tract of the androgen receptor (AR-polyQ). It has been shown that miR-196a enhanced the decay of the AR mRNA by silencing CUGBP, Elav-like family member 2 (CELF2). CELF2 shown to directly act on AR mRNA and enhance the stability of AR mRNA (Miyazaki et al., 2012) . Myotonic dystrophy (DM) is a neuromuscular disorder associated with CTG triplet repeat expansion in the myotonin protein kinase gene (DMPK). It has been suggested that the expanded CUG repeats sequester specific RNA-binding proteins and that such a sequestration results in abnormal RNA processing of several RNAs containing CUG repeats in multiple tissues affected in patients with DM. One of the members of the CUG-binding proteins, CUG-BP, has been identified previously (Lu et al., 1999) .
Development
Note
Overexpression of CELF2 by RNA microinjection resulted in severe defects in nervous system and gastrulation, suggesting the need for tight control of napor gene regulation during embryo development (Choi et al., 2003 ). CELF2 appears to be an important factor for thymus development and is therefore a candidate gene for the thymus hypoplasia/aplasia seen in partial monosomy 10p patients (Lichtner et al., 2002) .
